PlexZyme Binding


Class-leading PlexPCR® is the engine driving the entire SpeeDx product range, utilising two proprietary technologies: PlexZyme® and PlexPrime®. This technology enables high performance and reliable multiplex qPCR compared to other probe-based methods.


PlexPCR® tests combine multiple, clinically relevant infectious disease targets into a single test solution – simplifying patient diagnostics and streamlining patient management. Increase your instrument real estate by decreasing the number of wells required per sample.

PlexZyme binding to target and probe
Magnifying glass over graphs showing the results of DNA sequencing


ResistancePlus® tests combine organism detection with genetic markers linked to antibiotic susceptibility or resistance – providing valuable information to guide treatment decisions. Multiple single point mutations can be multiplexed into a single-well reaction to streamline workflow and maximise instrument realestate.

PlexZyme® Technology

Multiplexing Accelerated

Proprietary PlexZyme® technology provides 5-levels of specificity, market-leading multiplex performance and is the driver behind the entire SpeeDx product portfolio.

PlexPrime® Technology

Multiplex Mutation Detection

PlexPrime® is a novel method for nucleic acid amplification that creates amplicons which are distinctly different from the parent sequence. The combination of PlexPrime® and PlexZyme® technology enables multiplex mutation detection with high sensitivity and specificity.

Want SpeeDx technology in your laboratory?